Scale Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Scale Therapeutics General Information

Description

Developer of medical devices for tissue generation. The company develops medical devices for regenerative medicine using proprietary dextrin hydrogel technology that are mainly used as bone graft substitutes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Devices and Supplies
Primary Office
  • Braga Area
  • Portugal
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Scale Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 25-Jul-2014 Completed Startup
To view Scale Therapeutics’s complete valuation and funding history, request access »

Scale Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Building Global Innovators Accelerator/Incubator 000 0000 000000 0
To view Scale Therapeutics’s complete investors history, request access »